acetyl-l-carnitine diabetic neuropathy randomized trial doi in the Treatment of Peripheral Neuropathic Pain: A Systematic Review and Meta-Analysis of Controlled Trials acetyl-l-carnitine diabetic neuropathy randomized trial

Description

Mol Neurobiol

Dosage Forms and Strengths Tablets: 250 mg and 500 mg ( 3) Contraindications Hepatic disease or significant hepatic dysfunction ( 4, 5.1) Known mitochondrial disorders caused by mutations in mitochondrial DNA polymerase (POLG) ( 4, 5.1) Suspected POLG-related disorder in children under two years of age ( 4, 5.1) Known hypersensitivity to the drug ( 4, 5.12) Urea cycle disorders ( 4, 5.6) Prophylaxis of migraine headaches: Pregnant women, women of childbearing potential not using effective contraception ( 4, 8.1) Warnings and Precautions Birth defects, decreased IQ, and neurodevelopmental disorders following in uteroexposure: Should not be used to treat women with epilepsy or bipolar disorder who are pregnant or who plan to become pregnant or to treat a woman of childbearing potential unless other medications have failed to provide adequate symptom control or are otherwise unacceptable ( 5.2, 5.3, 5.4) Pancreatitis: Divalproex sodium extended-release tablets should ordinarily be discontinued ( 5.5) Suicidal behavior or ideation: Antiepileptic drugs, including divalproex sodium extended-release tablets, increase the risk of suicidal thoughts or behavior ( 5.7) Bleeding and other hematopoietic disorders: Monitor platelet counts and coagulation tests ( 5.8) Hyperammonemia and hyperammonemic encephalopathy: Measure ammonia level if unexplained lethargy and vomiting or changes in mental status, and also with concomitant topiramate use

doi: 10.1359/jbmr.090410

[PubMed 7856582] 1832

The fact that cysteine S -conjugate -lyase activity is widespread in enteric bacteria and that a major portion of cysteine S -conjugates are excreted into the bile suggests that the gut flora may be important for the incorporation of sulfur into some xenobiotics (Larsen and Stevens, 1986)